Melanie Lindenberg

Papers

Total Citations

H-Index

About

Melanie Lindenberg is a health outcomes researcher whose work sits at the intersection of urologic oncology and health economics. Her primary research focus is on evaluating the comparative effectiveness and cost-utility of surgical treatments for prostate cancer, specifically robot-assisted radical prostatectomy (RARP) versus laparoscopic prostatectomy. Lindenberg’s major contribution lies in providing robust, long-term functional outcome data to inform the ongoing debate about the added value of robotic surgery. Her landmark 2021 study, drawing on a large national retrospective cluster analysis from the Netherlands, demonstrated significantly improved long-term urinary functioning for patients undergoing RARP. This work, cited 18 times, directly challenged assumptions about equivalent outcomes between the two techniques. Building on this, her 2022 cost-utility analysis (27 citations) integrated these functional outcomes with economic modeling, providing crucial evidence for healthcare decision-makers weighing the higher upfront costs of robotic platforms against improved patient quality of life. By bridging clinical efficacy and economic sustainability, Lindenberg’s research offers a rigorous framework for value-based surgical care in oncology, making her a key voice in evidence-based urological practice.